Company: INMB
Filing Date: 2025-10-30
Form Type: 8-K
Source: 0001213900-25-104154
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-10-30
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item
2.02 Results of Operations and Financial Condition.

On
October 30, 2025, INmune Bio Inc. announced its financial results for the quarter ended September 30, 2025, and provided a business update.
The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on
Form 8-K.

The
information contained in Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly provided by specific reference in such filing.

Item
9.01 Financial statements and Exhibits